Breast Cancer: Personalized Risk Assessments for Medicare Patients
A senate committee must act next: committee consideration.
While breast cancer screening is a popular topic, this bill currently only has two Republican sponsors. It will need broad support from both parties to pass through the Senate Finance Committee.
Scores run from -100 (strongly harmful) to +100 (strongly beneficial) for each group, combining impact, certainty, scope, and duration ratings of 1-5. How impact scoring works
Creates a new CMS pilot payment model that reimburses doctors and other providers for giving Medicare patients ages 40 to 75 a deep genetic and lifestyle based breast cancer risk assessment, then building a personalized screening plan. Only people enrolled in traditional Medicare Part A or B, not Medicare Advantage, and without end stage renal disease or hospice care qualify, and only providers who choose to join the 7 year test can offer it.
“who has attained 40 years of age but has not attained 75 years of age”
Read twice and referred to the Committee on Finance.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in Senate
The bill was officially filed and given a number. It now enters the legislative queue.
No votes, news coverage, or related bills recorded for this bill yet.
Document Type
Congressional Bill
Official Title
PREFERRED Screening Act
Analysis generated by AI. Always verify with official sources.